Publicaciones en las que colabora con Francisco Javier Romero Gómez (49)

2024

  1. Small Extracellular Vesicles and Oxidative Pathophysiological Mechanisms in Retinal Degenerative Diseases

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2020

  1. Curcumin as a therapeutic option in retinal diseases

    Antioxidants, Vol. 9, Núm. 1

  2. Ethanol-induced oxidative stress modifies inflammation and angiogenesis biomarkers in retinal pigment epithelial cells (Arpe-19): Role of cyp2e1 and its inhibition by antioxidants

    Antioxidants, Vol. 9, Núm. 9, pp. 1-17

2019

  1. A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome

    Clinical Ophthalmology, Vol. 13, pp. 483-490

  2. Retinal function assessment in alcohol use disorder patients

    Journal of Drug and Alcohol Research, Vol. 8

2017

  1. Exosomes derived from stimulated monocytes promote endothelial dysfunction and inflammation in vitro

    Annals of Translational Medicine

2016

  1. Oxidative stress in retinal pigment epithelium cells increases exosome secretion and promotes angiogenesis in endothelial cells

    Journal of Cellular and Molecular Medicine, Vol. 20, Núm. 8, pp. 1457-1466

2011

  1. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion

    Archives of Ophthalmology, Vol. 129, Núm. 3, pp. 283-287

  2. Metabolic muscle damage and oxidative stress markers in an America's Cup yachting crew

    European Journal of Applied Physiology, Vol. 111, Núm. 7, pp. 1341-1350

2010

  1. Comparison of the acute effects of anti-TNF-alpha drugs on a uveitis experimental model

    Ocular Immunology and Inflammation, Vol. 18, Núm. 3, pp. 208-215

  2. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa

    Journal of Ocular Pharmacology and Therapeutics

2009

  1. Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema

    Journal of Ocular Pharmacology and Therapeutics, Vol. 25, Núm. 4, pp. 379-384

  2. Lutein prevents cataract development and progression in diabetic rats

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 247, Núm. 1, pp. 115-120

  3. Transient bevacizumab (avastin)-induced alterations in rat eyes

    Ophthalmic Research, Vol. 41, Núm. 1, pp. 28-35

  4. Vitrectomía enzimática por inyección intravítrea de plasmina autóloga como tratamiento inicial de las membranas epirretinianas maculares y el síndrome de tracción vitreomacular

    Archivos de la Sociedad Española de Oftalmologia, Vol. 84, Núm. 2, pp. 91-100

2008

  1. Adalimumab therapy for refractory uveitis: A pilot study

    Journal of Ocular Pharmacology and Therapeutics, Vol. 24, Núm. 3, pp. 351-361

  2. Aqueous humor levels of vascular endothelial growth factor in retinitis pigmentosa

    Investigative Ophthalmology and Visual Science, Vol. 49, Núm. 8, pp. 3499-3502

  3. Chronic alcohol feeding induces biochemical, histological, and functional alterations in rat retina

    Alcohol and Alcoholism, Vol. 43, Núm. 3, pp. 254-260

  4. Plasmina autóloga intravítrea sin asociar vitrectomía: Vitreolisis farmacológica, método perfeccionado con uroquinasa

    Archivos de la Sociedad Española de Oftalmologia, Vol. 83, Núm. 5, pp. 291-292

  5. Reply to Callejas-Rubio et al.

    Journal of Ocular Pharmacology and Therapeutics